News center

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi

Owkin and BeOne Medicines Sign Clinical Supply Agreement for Tislelizumab in INVOKE Trial of OKN4395

AstraZeneca pens agentic AI licensing deal with Owkin

Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca

Éric Durand (Owkin): We’re moving from Co-pilot AI towards automated researchers

Business Next features Owkin about accelerating drug discovery

Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing

Owkin Announces Partnership with Consensus to Strengthen Literature Intelligence for Owkin’s AI Scientist, K Pro

NHS Lothian joins Owkin’s patient data network with multi-year partnership

Global AI Impact Summit 2026, India: Owkin strengthens its strategic partnerships with India to advance biological artificial super intelligence

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs